XUNDRIA owner Contact Information online
from Eli Lilly and Company
XUNDRIA
US serial number:85067824
Application filling date:Jun. 21, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 17, 2014
Publication date:Nov. 16, 2010
Abandoned date:Feb. 17, 2014
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer/oncology
International Class(es): 005- Primary Class
U.S Class(es): 006,018,044,046,051,052
Class Status: ACTIVE
Basis: 1(b)
Services:Pharmaceutical preparations
namely
pharmaceutical preparations for the treatment of cancer/oncology
Current owner owner name:Eli Lilly and Company
Current owner owner address:Lilly Corporate Center
Indianapolis,
INDIANA
UNITED STATES
46285
Current owner legal entity type:CORPORATION
Current owner state or country:INDIANA
Attorney name:Robert E. Lee, Jr.
Attorney email:trademarks@lilly.com
Attorney email authorized:Yes
Correspondent name address:ROBERT E. LEE, JR.
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS,
INDIANA
UNITED STATES
46285-0001
Correspondent phone:317 276 9624
Correspondent email:trademarks@lilly.com
Correspondent fax:317 276 1919
Correspondent email authorized:Yes
Trademark staff tm attorney:FARRELL, ANNE M
Trademark staff law office assigned XUNDRIA:LAW OFFICE 118
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (131) JOHNSON & JOHNSON (127) Eli Lilly and Company (61) Millennium Pharmaceuticals, Inc. (54) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) S. C. Johnson & Son, Inc. (31) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Nov. 16, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Mar. 29, 2011 Apr. 12, 2011 Apr. 19, 2011 Oct. 19, 2010 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
